Effect of Brisk Walking on Primary Dysmenorrhea

September 4, 2022 updated by: Ain Shams University

Effect of Brisk Walking on Primary Dysmenorrhea Among Medical Students

Dysmenorrhea is a common problem in women. Exercise is commonly cited as a possible remedy. We will measure the effect of brisk walking on primary dysmenorrhea among medical students.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

170

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 002
        • AinShams Maternity Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

17 years to 25 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • BMI: 18-25
  • regular menstrual cycles

Exclusion Criteria:

  • Marriage or previous sexual activity
  • medical disorders
  • previous abdominal or pelvic surgery
  • skeletal disorders
  • hormonal or psychiatric treatment
  • atheletes

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
No intervention
Active Comparator: Exercise group
Will brisk walk 30 minutes 3 times weekly
Walking

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dysmenorrhea score
Time Frame: 3 months
WaLIDD (working ability, location, intensity, days of pin, dysmenorrhea)score for dysmenorrhea. Least is 0, highest is 12. The higher the score, the worse dysmenorrhea
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Maii Nawara, MD, Ain Shams University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 24, 2021

Primary Completion (Actual)

February 12, 2022

Study Completion (Actual)

May 20, 2022

Study Registration Dates

First Submitted

April 17, 2021

First Submitted That Met QC Criteria

April 17, 2021

First Posted (Actual)

April 21, 2021

Study Record Updates

Last Update Posted (Actual)

September 7, 2022

Last Update Submitted That Met QC Criteria

September 4, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • M D 59/2021

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

IPD will be available with the principal investigator and will be shared if requested

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe